Stabilized Antimicrobial Peptide via Non-Covalent Bonding and Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antimicrobial peptides (AMPs) are sensitive to pH and temperature changes, and susceptible to enzymatic degradation and hydrophobic aggregation, limiting their application in commercial products.
Innovation Solution
An acid and alkali-resistant, thermostabilized AMP is developed by bonding the peptide with a structure-lock component through a non-covalent bond to maintain its native conformation, and encapsulating it within a controlled-release encapsulation material.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antimicrobial peptides are used as preservatives, then antimicrobial effectiveness is improved, but stability under pH and temperature changes deteriorates
Solution Approach 1:
The antimicrobial peptide is encapsulated within a core-shell nanoparticle structure where the peptide resides in the core region stabilized by structure-lock components, while the shell provides environmental protection. This nested architecture allows the peptide to maintain its antimicrobial effectiveness while being shielded from pH and temperature variations.
Solution Approach 2:
The invention creates a composite nanoparticle system combining multiple components: the antimicrobial peptide, structure-lock components (such as cyclodextrins or peptides with constrained structures), and shell materials (such as phospholipids or biopolymers). This composite structure integrates the antimicrobial function with stability-providing elements to resolve the contradiction between effectiveness and environmental stability.
2Reliability
If antimicrobial peptides are used as preservatives, then broad-spectrum antimicrobial properties are improved, but susceptibility to enzymatic degradation deteriorates
Solution Approach 1:
The peptide is nested within the core of the nanoparticle, surrounded by structure-lock components and shell material that provide physical and chemical protection against enzymatic attack. This nested configuration allows the peptide to maintain broad-spectrum antimicrobial properties while being protected from enzymatic degradation in the external environment.
Solution Approach 2:
The shell layer of the nanoparticle acts as a flexible protective barrier that prevents enzymatic access to the embedded peptide while allowing the peptide to function when released at the target site. This shell structure resolves the contradiction by providing enzymatic protection without compromising antimicrobial activity.
3Object-affected harmful factors
If antimicrobial peptides are used as preservatives, then low toxicity is improved, but hydrophobic aggregation deteriorates
Solution Approach 1:
The shell layer of the nanoparticle provides a hydrophilic interface with the aqueous environment, preventing hydrophobic aggregation of the peptide while maintaining its low toxicity. The shell acts as a stabilizing barrier that keeps the peptide in a dispersed, monomeric state, resolving the contradiction between preventing aggregation and maintaining biocompatibility.
Solution Approach 2:
The encapsulation process changes the physical state and microenvironment of the peptide from a free, potentially aggregating state to a confined, stabilized state within the nanoparticle. This parameter change in the peptide's physical environment prevents hydrophobic aggregation while preserving its low toxicity and antimicrobial function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting AMP demonstrates exceptional stability and antimicrobial efficacy across a wide pH range (4-10) and temperature range (0-120°C), achieving at least 99% antimicrobial effect against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Implementation Method 1
bonded with a structure-lock component through a non-covalent bond to maintain the AMP in its native conformation
Implementation Method 2
encapsulated by a controlled release encapsulation material
Implementation Method 3
the structure-lock component binds to hydrophobic residues of the AMP
Data Source
AI summary
An acid and alkali-resistant, as well as thermostabilized antimicrobial peptide is provided. This peptide is engineered to endure extreme pH conditions, high temperatures, and sustain its natural conformation. This is achieved by bonding the antimicrobial peptide with a structure-lock component via non-covalent interactions, effectively preserving its biologically active conformation. Moreover, the antimicrobial peptide is enveloped within a controlled release encapsulation material, facilitating controlled and sustained release in diverse applications.